Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Top Japanese Pharmas Show Appetite For Emerging Market Expansion, Will Generics Follow?

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japanese pharma companies are trying to determine how to expand into new markets, ranging from the U.S. to China, and IMS Health data show a slow move away from dependence on the domestic market for Japan's leading companies
Advertisement

Related Content

EFPIA Hopes To Shift Conversation In Japan From Pricing To Funding
Alliances Up In Japan, And A Shift To Overseas Markets
Alliances Up In Japan, And A Shift To Overseas Markets
PharmAsia News Favorite Stories From 2011
After Years Of Partner Search, India's Dr. Reddy's Forms JV With Fujifilm To Tap Japanese Generics Market
Takeda Finally Reveals €9.6B Nycomed Acquisition; Sheds Dermatology Business, But Otherwise Set On Retention
Mitsubishi Tanabe's Key Products And M&A Rumors Tempered By Management Issues
Mitsubishi Tanabe's Key Products And M&A Rumors Tempered By Management Issues
Sanofi-Aventis And Nichi-Iko Announce JV For Generics In Japan
Ranbaxy Officially Becomes A Daiichi Subsidiary As Management Turns To Business Synergies
Advertisement
UsernamePublicRestriction

Register

SC078709

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel